Sentinel Offers Drug Firms ‘Unique’ Venue For Post-Market Studies, Pfizer Says

Pfizer’s experience in piloting an approach to using US FDA’s Sentinel data network for post-market research demonstrated the feasibility and benefits of doing so.

More from Post-Marketing Regulation & Studies

More from Product Reviews